{
  "actions": [
    {
      "acted_at": "2017-07-31", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-07-31", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1681-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "115", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-07-31", 
  "number": "1681", 
  "official_title": "A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr3536-115", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": null, 
  "sponsor": {
    "bioguide_id": "S000033", 
    "district": null, 
    "name": "Sanders, Bernard", 
    "state": "VT", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-07-31", 
  "subjects": [
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Health programs administration and funding", 
    "Health technology, devices, supplies", 
    "Inflation and prices", 
    "Intellectual property", 
    "Medical research", 
    "Research and development"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2017-07-31T04:00:00Z", 
    "text": "This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:38:28Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s1681.xml"
}